Nonetheless, the mechanism through which GM-CSF promotes antigen presentation along with the cellular processes that manifest the dual control of both inflammatory as well as anti-inflammatory cytokines in APCs needs to be fully understood to ascertain the therapeutic potential of GM-CSF against TB. The gene discussed is CSF2; the disease is tuberculosis.